Search Results 561-570 of 15259 for TNF
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Help Fund Research.
A study of tolododekin alfa (also known as ANK-101) administered in combination with an anti-programmed cell death protein 1 (PD-1)/programmed cell death ligand ...
OBJECTIVES: Primary Objective: To examine the efficacy of targeting atrial fibrosis tissue during an ablation procedure in treating persistent AF. Results from ...
The objective of this study is to collect blood samples from living patients with neurofibromatosis type 1 (NF1) for future genomic, proteomic, metabolomic, and ...
Fatigue is a common symptom. Almost everyone feels it during short-term illness. Fortunately, fatigue usually goes away when the illness is over.
Mayo Clinic investigators are making new discoveries in the areas of cause, prevention and treatment of NAFLD . Their findings are helping to improve patient ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researchers study genetics, causes and new treatments for people with neurofibromatosis type 1. Research is conducted by Mayo Clinic researchers in ...
Find out how healthcare teams use innovative treatments such as transoral robotic surgery and proton therapy to treat this type of throat cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.